Literature DB >> 8452659

Tryptophan. Current status and future trends for oral administration.

L D Kaufman1, R M Philen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8452659     DOI： 10.2165/00002018-199308020-00001

Source DB:  PubMed          Journal:  Drug Saf        ISSN： 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  61 in total

Review 1.  The eosinophilia-myalgia syndrome: current concepts and future directions.

Authors:  L D Kaufman
Journal:  Clin Exp Rheumatol       Date:  1992 Jan-Feb       Impact factor: 4.473

2.  Diffuse fasciitis with eosinophilia: a new syndrome?

Authors:  L E Shulman
Journal:  Trans Assoc Am Physicians       Date:  1975

3.  Clinical spectrum of the systemic manifestations of the eosinophilia-myalgia syndrome.

Authors:  J Varga; T D Heiman-Patterson; D L Emery; R Griffin; E V Lally; J J Uitto; S A Jimenez
Journal:  Semin Arthritis Rheum       Date:  1990-06       Impact factor: 5.532

4.  Eosinophilic fasciitis associated with the eosinophilia-myalgia syndrome.

Authors:  I Jaffe; R Kopelman; R Baird; M Grossman; A Hays
Journal:  Am J Med       Date:  1990-05       Impact factor: 4.965

5.  Eosinophilia-myalgia syndrome. Results of national surveillance.

Authors:  L A Swygert; E F Maes; L E Sewell; L Miller; H Falk; E M Kilbourne
Journal:  JAMA       Date:  1990-10-03       Impact factor: 56.272

6.  Toxic epidemic syndrome, Spain, 1981. Toxic Epidemic Syndrome Study Group.

Authors: 
Journal:  Lancet       Date:  1982-09-25       Impact factor: 79.321

7.  L-tryptophan ingestion associated with eosinophilic fasciitis but not progressive systemic sclerosis.

Authors:  B Freundlich; V P Werth; A H Rook; C R O'Connor; H R Schumacher; J J Leyden; P D Stolley
Journal:  Ann Intern Med       Date:  1990-05-15       Impact factor: 25.391

Review 8.  Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome.

Authors:  J G Lanham; K B Elkon; C D Pusey; G R Hughes
Journal:  Medicine (Baltimore)       Date:  1984-03       Impact factor: 1.889

9.  An investigation of the cause of the eosinophilia-myalgia syndrome associated with tryptophan use.

Authors:  E A Belongia; C W Hedberg; G J Gleich; K E White; A N Mayeno; D A Loegering; S L Dunnette; P L Pirie; K L MacDonald; M T Osterholm
Journal:  N Engl J Med       Date:  1990-08-09       Impact factor: 91.245

10.  L-tryptophan and eosinophilia-myalgia syndrome in New Mexico.

Authors:  M Eidson; R M Philen; C M Sewell; R Voorhees; E M Kilbourne
Journal:  Lancet       Date:  1990-03-17       Impact factor: 79.321
View more
  2 in total

Review 1.  Toxic myopathies.

Authors:  Mamatha Pasnoor; Richard J Barohn; Mazen M Dimachkie
Journal:  Neurol Clin       Date:  2014-08       Impact factor: 3.806

2.  Effect of orally administered dipterinyl calcium pentahydrate on oral glucose tolerance in diet-induced obese mice.

Authors:  Svetlana E Nikoulina; Dietmar Fuchs; Phillip Moheno
Journal:  Diabetes Metab Syndr Obes       Date:  2012-02-24       Impact factor: 3.168
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.